Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

755 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CB1 antagonists for obesity--what lessons have we learned from rimonabant?
Di Marzo V, Després JP. Di Marzo V, et al. Nat Rev Endocrinol. 2009 Nov;5(11):633-8. doi: 10.1038/nrendo.2009.197. Nat Rev Endocrinol. 2009. PMID: 19844251
2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite.
Di Marzo V. Di Marzo V. Biochemistry (Mosc). 1998 Jan;63(1):13-21. Biochemistry (Mosc). 1998. PMID: 9526090 Review.
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
Di Marzo V. Di Marzo V. Biochim Biophys Acta. 1998 Jun 15;1392(2-3):153-75. doi: 10.1016/s0005-2760(98)00042-3. Biochim Biophys Acta. 1998. PMID: 9630590 Review.
Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L. Di Marzo V, et al. FEBS Lett. 1998 Oct 9;436(3):449-54. doi: 10.1016/s0014-5793(98)01175-2. FEBS Lett. 1998. PMID: 9801167
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Di Marzo V, et al. Trends Neurosci. 1998 Dec;21(12):521-8. doi: 10.1016/s0166-2236(98)01283-1. Trends Neurosci. 1998. PMID: 9881850 Review.
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin.
Bisogno T, Melck D, De Petrocellis L, Di Marzo V. Bisogno T, et al. Among authors: di marzo v. J Neurochem. 1999 May;72(5):2113-9. doi: 10.1046/j.1471-4159.1999.0722113.x. J Neurochem. 1999. PMID: 10217292
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
Di Marzo V, De Petrocellis L, Bisogno T, Melck D. Di Marzo V, et al. Lipids. 1999;34 Suppl:S319-25. doi: 10.1007/BF02562332. Lipids. 1999. PMID: 10419192 Review.
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
Di Marzo V. Di Marzo V. Life Sci. 1999;65(6-7):645-55. doi: 10.1016/s0024-3205(99)00287-8. Life Sci. 1999. PMID: 10462065 Review.
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells.
Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzmán M, Di Marzo V. Melck D, et al. Among authors: di marzo v. FEBS Lett. 1999 Dec 17;463(3):235-40. doi: 10.1016/s0014-5793(99)01639-7. FEBS Lett. 1999. PMID: 10606728
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V. Melck D, et al. Among authors: di marzo v. Endocrinology. 2000 Jan;141(1):118-26. doi: 10.1210/endo.141.1.7239. Endocrinology. 2000. PMID: 10614630
755 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback